Should Lemonade Be in Your Portfolio This Summer?
Although insurance companies benefit from rising interest rates, Lemonade (LMND) failed to surpass the consensus EPS estimate in the last reported quarter. Analysts expect its EPS to remain negative in...
Although insurance companies benefit from rising interest rates, Lemonade (LMND) failed to surpass the consensus EPS estimate in the last reported quarter. Analysts expect its EPS to remain negative in fiscal 2022 and 2023. So, will LMND be able to turn around in this rising interest rate environment? Read on to find our view….
Lemonade, Inc. (LMND) provides various insurance products in the United States and Europe. Its products cover stolen or damaged property and personal liability. The company also offers renters, homeowners, pets, life insurance products, and landlord insurance policies. In addition, it operates as an agent for other insurance companies.
The consumer price index data revealed that inflation had risen 8.6% in May from the year-ago period, the highest since December 1981. In its efforts to tame the surging inflation, the Federal Reserve has increased the benchmark interest rates thrice this year, with the recent 75 basis-point increase happening to be its most aggressive rate hike since 1994.
In a rising interest rate environment, insurers usually benefit. Higher bond yields increase the risk-free returns of insurance companies because they invest in high-grade fixed income instruments to meet their promised returns to policyholders.
For the first quarter ended March 31, LMND reported an 88.5% year-over-year increase in revenue. However, its net loss and adjusted EBITDA loss widened. Moreover, the customer growth declined over the last five quarters. Despite increasing 66% to $419 million in the previous quarter, the company’s in-force premium (IFP) is on a downtrend.
LMND’s stock has declined 54.3% in price year-to-date and 82.6% over the past year to close the last trading session at $19.23. The stock is currently trading 83.4% below its 52-week high of $115.85.
Here’s what could influence LMND’s performance in the upcoming months:
LMND’s net loss widened 52.6% year-over-year to $74.80 million for the first quarter ended March 31, 2022. The company’s adjusted EBITDA loss widened 38.9% year-over-year to $57.40 million. Also, its total expense increased 63.2% year-over-year to $116.90 million. In addition, its loss per share widened 49.3% year-over-year.
Mixed Analyst Estimates
Analysts expect LMND’s revenue for fiscal 2022 and 2023 to increase 66.2% and 54.1% year-over-year to $213.41 million and $328.87 million, respectively. However, its earnings per share for fiscal 2022 and 2023 are expected to remain negative.
In terms of forward P/B, LMND’s 2.14x is 99.2% higher than the 1.08x industry average. Likewise, its 5.74x forward P/S is 102.7% higher than the 2.83x industry average. And the stock’s 4.75x forward EV/S is 78.8% higher than the 2.66x industry average.
LMND’s trailing-12-month net income margin is negative compared to the 29.01% industry average. Likewise, its trailing-12-month EBITDA margin is negative compared to the 23.03% industry average. Furthermore, the stock’s 0.10% trailing-12-month asset turnover ratio is 51.8% lower than the industry average of 0.21%.
POWR Ratings Reflect Bleak Prospects
LMND has an overall F rating, equating to a Strong Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. LMND has an F grade for Value, in sync with its stretched valuation.
It has a D grade for Quality, consistent with its negative levered FCF margin compared to the 17.46% industry average. Furthermore, its disappointing financials justify its D grade for Growth.
Although the rising interest rate environment bodes well for insurers, LMND’s EPS is expected to remain negative in fiscal 2022 and 2023. The stock is currently trading below its 50-day and 200-day moving averages of $20.27 and $38.04, respectively, indicating a downtrend.
Given its disappointing earnings, stretched valuation, and lower-than-industry profitability, we think it could be wise to avoid the stock now.
How Does Lemonade, Inc. (LMND) Stack Up Against Its Peers?
LMND has an overall POWR Rating of F, equating to a Strong Sell rating. Therefore, one might want to consider investing in the following Insurance – Property & Casualty stocks with a B (Buy) rating, such as W. R. Berkley Corporation (WRB) and Loews Corporation (L).
LMND shares were unchanged in premarket trading Wednesday. Year-to-date, LMND has declined -54.33%, versus a -19.26% rise in the benchmark S&P 500 index during the same period.
About the Author: Dipanjan Banchur
Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets.
Entrepreneur Editors' Picks
How Millionaires Prepare for a Recession, According to a Former Wall Street Trader
5 Self-Care Habits of Every Successful Entrepreneur
Listen Closely to What People Ask You. That's Where to Find Your Hidden Power.
Gen Z Customers Want More. This 3-Step Strategy Will Help Your Company Give It to Them.
This Founder Was Madly Pulling a Pandemic Pivot When...the FBI Showed Up at Her Door With Guns, Seized Her Money and Told Her Husband He Was the Target of a Criminal Investigation
Take Customer Service to the Next Level With These Service-Based Franchises
Define Your Short-Term Goals With These 3 Components for Long-Term Success